Symptom improvement and residual symptoms during acute antidepressant treatment in pediatric major depressive disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 20, Issue 5, 2010, Pages 423-430

  Tao, Rongrong ^a,b   Emslie, Graham J ^a,b   Mayes, Taryn L ^a,b   Nakonezny, Paul A ^a   Kennard, Betsy D ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Children's Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; DRUG DOSE INCREASE; FEMALE; HUMAN; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; RATING SCALE; SCHEDULE FOR AFFECTIVE DISORDERS AND SCHIZOPHRENIA; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHILD; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUOXETINE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77958577384     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2009.0116     Document Type: Article

References (19)

1. th edition (DSM-IV). Washington (DC): American Psychiatric Association, 1994.
2. Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc 57:289-300, 1995.
3. Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J: A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 54:1031-1037, 1997.
4. Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, Nilsson M, Jacobson JG: Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 41:1205-1215, 2002.
5. Emslie GJ, Kennard BD, Mayes TL, Nightingale-Teresi J, Carmody T, Hughes CW, Rush AJ, Tao R, Rintelmann JW: Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry 165:459-467, 2008.
6. Fava G, Rafanelli C, Grandi S, Conti S, Belluardo P: Prevention of recurrent depression with cognitive behavioral therapy: Preliminary findings. Arch Gen Psychiatry 55:816-820, 1998.
7. Guo Y, Nilsson ME, Heiligenstein J, Wilson MG, Emslie G: An exploratory factor analysis of the Children's Depression Rating Scale-revised. J Child Adolesc Psychopharmacol 16:482-491, 2006.
8. Guy W: ECDEU Assessment Manual for Psychopharmacology. Washington (DC): US Government Printing Office, 1976, pp 76-338.
9. Hedges L, Olkin I: Statistical methods for meta-analysis. Orlando (Florida): Academic Press, 1985.
10. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997.
11. Kennard B, Silva S, Vitiello B, Curry J, Kratochvil C, Simons A, Hughes J, Feeny N, Weller E, Sweeney M, Reinecke M, Pathak S, Ginsburg G, Emslie G, March J: Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 45:1404-1411, 2006. (Pubitemid 44900913)
12. Kenward MG, Roger JH: Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53:983-997, 1997.
13. Kratochvil C, Emslie G, Silva S, McNulty S, Walkup J, Curry J, Reinecke M, Vitiello B, Rohde P, Feeny N, Casat C, Pathak S, Weller E, May D, Mayes T, Robins M, March J: Acute time to response in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 45:1412-1418, 2006. (Pubitemid 44900914)
14. Mallinckrodt CH, Sanger TM, Dube S, DeBrota DJ, Molenberghs G, Carroll RJ, Potter WZ, Tollefson GD: Assessing and interpreting treatment effects in longitudinal clinical trials with missing data. Biol Psychiatry 53:754-760, 2003.
15. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J: Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 292:807-820, 2004. (Pubitemid 39079667)
16. Padilla M, Algina J: Type I error rates of the Kenward-Roger adjusted degree of freedom F-test for a split-plot design with missing values. J Modern Appl Statist Methods 6:66-80, 2007.
17. Poznanski E, Mokros H: Children's Depression Rating Scale-Revised (CDRS-R). Los Angeles: WPS, 1996.
18. Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF: Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 31:1841-1853, 2006.
19. Tao R, Emslie G, Mayes T, Nakonezny P, Kennard B and Hughes C: Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder. J Am Acad Child Adolesc Psychiatry 48:71-78, 2009.